Trial
NCT04611958
Intraductal Liposomal Bupivacaine for Chronic Pancreatitis
Early Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Johns Hopkins University
Collaborators
—
Condition
Chronic Pancreatitis
Intervention
ERCP with Bupivacaine infusion
Why stopped
The FDA requirements for the IND are not feasible to complete.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-07-21